Rapid Novor
1 known investors
Rapid Novor provides mass spectrometry-based protein and antibody sequencing services, including monoclonal and polyclonal antibody sequencing, epitope mapping, and antibody-antigen interaction analysis, for biotech and pharmaceutical companies. It also offers EasyM, a CLIA-accredited clinical test for tracking multiple myeloma via protein sequencing.
Investors Β· 1
Frequently asked questions
- What does Rapid Novor do?
- Rapid Novor provides mass spectrometry-based protein and antibody sequencing services, including monoclonal and polyclonal antibody sequencing, epitope mapping, and antibody-antigen interaction analysis, for biotech and pharmaceutical companies. It also offers EasyM, a CLIA-accredited clinical test for tracking multiple myeloma via protein sequencing.
- Who are Rapid Novor's investors?
- Rapid Novor's investors include China Growth Capital.